Literature DB >> 26925437

A novel low-volume two-chamber microfabricated platform for evaluating drug metabolism and toxicity.

Shyam Sundhar Bale1, Gautham Vivek Sridharan1, Inna Golberg1, Ljupcho Prodanov1, William J McCarty1, Osman Berk Usta1, Rohit Jindal1, Martin L Yarmush2.   

Abstract

To evaluate drug and metabolite efficacy on a target organ, it is essential to include metabolic function of hepatocytes, and to evaluate metabolite influence on both hepatocytes and the target of interest. Herein, we have developed a two-chamber microfabricated device separated by a membrane enabling communication between hepatocytes and cancer cells. The microscale environment created enables cell co-culture in a low media-to-cell ratio leading to higher metabolite formation and rapid accumulation, which is lost in traditional plate cultures or other interconnected models due to higher culture volumes. We demonstrate the efficacy of this system by metabolism of tegafur by hepatocytes resulting in cancer cell toxicity.

Entities:  

Year:  2015        PMID: 26925437      PMCID: PMC4764261          DOI: 10.1142/S2339547815200034

Source DB:  PubMed          Journal:  Technology (Singap World Sci)


  18 in total

1.  Prototyping of microfluidic devices in poly(dimethylsiloxane) using solid-object printing.

Authors:  J Cooper McDonald; Michael L Chabinyc; Steven J Metallo; Janelle R Anderson; Abraham D Stroock; George M Whitesides
Journal:  Anal Chem       Date:  2002-04-01       Impact factor: 6.986

Review 2.  Why drugs fail--a study on side effects in new chemical entities.

Authors:  D Schuster; C Laggner; T Langer
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 3.  Microfluidic cell culture.

Authors:  Matthias Mehling; Savaş Tay
Journal:  Curr Opin Biotechnol       Date:  2013-11-12       Impact factor: 9.740

4.  Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration.

Authors:  J C Dunn; M L Yarmush; H G Koebe; R G Tompkins
Journal:  FASEB J       Date:  1989-02       Impact factor: 5.191

5.  Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform.

Authors:  Manjunath Hegde; Rohit Jindal; Abhinav Bhushan; Shyam Sundhar Bale; William J McCarty; Inna Golberg; O Berk Usta; Martin L Yarmush
Journal:  Lab Chip       Date:  2014-04-28       Impact factor: 6.799

Review 6.  Liver tissue engineering in the evaluation of drug safety.

Authors:  Ajit Dash; Walker Inman; Keith Hoffmaster; Samantha Sevidal; Joan Kelly; R Scott Obach; Linda G Griffith; Steven R Tannenbaum
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-10       Impact factor: 4.481

7.  A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs.

Authors:  Jong Hwan Sung; Michael L Shuler
Journal:  Lab Chip       Date:  2009-02-20       Impact factor: 6.799

8.  Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.

Authors:  P Chao; T Maguire; E Novik; K-C Cheng; M L Yarmush
Journal:  Biochem Pharmacol       Date:  2009-05-20       Impact factor: 5.858

Review 9.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

10.  Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity.

Authors:  Monika Szabo; Zsuzsa Veres; Zsolt Baranyai; Ferenc Jakab; Katalin Jemnitz
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  6 in total

1.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

2.  Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors.

Authors:  Yu Shrike Zhang; Julio Aleman; Su Ryon Shin; Tugba Kilic; Duckjin Kim; Seyed Ali Mousavi Shaegh; Solange Massa; Reza Riahi; Sukyoung Chae; Ning Hu; Huseyin Avci; Weijia Zhang; Antonia Silvestri; Amir Sanati Nezhad; Ahmad Manbohi; Fabio De Ferrari; Alessandro Polini; Giovanni Calzone; Noor Shaikh; Parissa Alerasool; Erica Budina; Jian Kang; Nupura Bhise; João Ribas; Adel Pourmand; Aleksander Skardal; Thomas Shupe; Colin E Bishop; Mehmet Remzi Dokmeci; Anthony Atala; Ali Khademhosseini
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

Review 3.  Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.

Authors:  David J Hughes; Tomasz Kostrzewski; Emma L Sceats
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-15

Review 4.  Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.

Authors:  Shyam Sundhar Bale; Laura Moore; Martin Yarmush; Rohit Jindal
Journal:  Tissue Eng Part B Rev       Date:  2016-06-01       Impact factor: 6.389

5.  New technologies in drug metabolism and toxicity screening: organ-to-organ interaction.

Authors:  Abhinav Bhushan; Nicole J Martucci; O Berk Usta; Martin L Yarmush
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-03-21       Impact factor: 4.481

6.  Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response.

Authors:  Shyam Sundhar Bale; Sharon Geerts; Rohit Jindal; Martin L Yarmush
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.